Apixaban Impurity 4 (BMS-728626-01)(CAS: 1686149-74-5)

Apixaban Impurity 4 (CAS: 1686149-74-5) falls under the regulatory guidelines of the Chemicals in the Environment (Chemical Safety) Regulations. It is also subject to the REACH regulations for registration, evaluation, authorization, and restriction of chemicals. Additionally, the FDA and EPA have specific requirements for the handling and disposal of this impurity. Regulatory compliance is essential for ensuring safety and environmental protection.

In synthesizing compounds similar to Apixaban Impurity 4 (CAS: 1686149-74-5), there are several alternatives such as other isomers or analogs. Common substitutes include different functional groups or structural modifications. For instance, using alternative reagents like different alkylating agents or adjusting reaction conditions can yield similar impurities with varying properties.

The market and research trends for Apixaban Impurity 4 (CAS: 1686149-74-5) are closely tied to the development and regulatory status of Apixaban. As a key impurity in Apixaban production, research is focused on understanding its biological effects and potential environmental impact. Market trends show a growing interest in the purity and safety of pharmaceuticals, driving the need for precise control and characterization of such impurities.

Waste containing Apixaban Impurity 4 (CAS: 1686149-74-5) should be managed according to environmental regulations. Proper collection and storage in designated containers are crucial. For disposal, consider incineration or professional waste disposal services. Environmental protection measures include minimizing exposure and ensuring that the waste is handled by trained professionals to prevent contamination and ensure compliance with local, national, and international environmental laws.